Monday.com: Q3 Earnings Snapshot

ImmunityBio (NASDAQ:IBRX) Announces Earnings Results

ImmunityBio (NASDAQ:IBRX - Get Free Report) posted its quarterly earnings results on Monday. The company reported ($0.09) EPS for the quarter, missing the consensus estimate of ($0.07) by ($0.02). The firm had revenue of $48.84 million for the quarter, compared to analyst estimates of $59.23 million.

ImmunityBio: Q3 Earnings Snapshot

SAN DIEGO (AP) — SAN DIEGO (AP) — ImmunityBio, Inc. (IBRX) on Monday reported a loss of $184.6 million in its third quarter.

Virtus Investment Non-GAAP EPS of $5.86 beats by $0.08, revenue of $197.6M beats by $16.24M (VRTS:NYSE)

Virtus Investment Q3 results: EPS beat, revenue topped estimates, and cash rose.

Monday.com: Q3 Earnings Snapshot

TEL AVIV-YAFO, Israel (AP) — TEL AVIV-YAFO, Israel (AP) — Monday.com Ltd. (MNDY) on Monday reported third-quarter earnings of $35.2 million.

LoanDepot: Q3 Earnings Snapshot

IRVINE, Calif. (AP) — IRVINE, Calif. (AP) — LoanDepot Inc. (LDI) on Monday reported a loss of $19.7 million in its third quarter.

ImmunityBio (IBRX) Stock Falls 18% Despite Cancer Trial Win and 92% Sales Growth

TLDR IBRX stock fell about 18% on Monday after a busy round of company news. Q3 net product revenue hit $48.7 million, up 53%, and nine-month revenue rose 92% to $143.6 million. ANKTIVA plus BCG met its primary goal in Cohort A of the QUILT-2.005 trial. Q3 net loss to common stockholders grew to $184.6 [...]